Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Elsevier Science full text link Elsevier Science Free PMC article
Full text links

Actions

Share

.2020 Nov:226:45-54.e1.
doi: 10.1016/j.jpeds.2020.08.003. Epub 2020 Aug 5.

Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review

Affiliations

Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review

Joseph Y Abrams et al. J Pediatr.2020 Nov.

Abstract

Objective: To develop a more comprehensive description of multisystem inflammatory syndrome in children (MIS-C), a novel syndrome linked to severe acute respiratory syndrome coronavirus 2, by conducting a systematic analysis of studies from different settings that used various inclusion criteria.

Study design: MIS-C studies were identified by searching PubMed and Embase as well as preprint repositories and article references to identify studies of MIS-C cases published from April 25, 2020, through June 29, 2020. MIS-C study metadata were assessed and information on case demographics, clinical symptoms, laboratory measurements, treatments, and outcomes were summarized and contrasted between studies.

Results: Eight studies were identified representing a total of 440 MIS-C cases. Inclusion criteria varied by study: 3 studies selected patients diagnosed with Kawasaki disease, 2 required cardiovascular involvement, and 3 had broader multisystem inclusion criteria. Median age of patients by study ranged from 7.3 to 10 years, and 59% of patients were male. Across all studies, the proportion of patients with positive results for severe acute respiratory syndrome coronavirus 2 reverse transcriptase-polymerase chain reaction tests ranged from 13% to 69% and for serology, from 75% to 100%. Patients with MIS-C had high prevalence of gastrointestinal (87%), dermatologic/mucocutaneous (73%), and cardiovascular (71%) symptoms. Prevalence of cardiovascular, neurologic, and respiratory system involvement significantly differed by study inclusion criteria. All studies reported elevated C-reactive protein, interleukin-6, and fibrinogen levels for at least 75% of patients in each study.

Conclusions: This systematic review of MIS-C studies assists with understanding this newly identified syndrome and may be useful in developing a refined, universal case definition of MIS-C.

Published by Elsevier Inc.

PubMed Disclaimer

Figures

Figure 2
Figure 2
Proportion of patients with clinical symptoms in different organ systems by study. Size ofcircles is relative to study sample size, andshapes represent categories of inclusion criteria.Gray bars represent the prevalence of organ system involvement in patients in all studies. Not all studies reported involvement for each organ system. Point labels denote studies: W = Whittaker, V = Verdoni, B = Belhadjer, T = Toubiana, D = Dufort, F = Feldstein, R = Ramcharan, and P = Pouletty. Studies with inclusion criteria of CVD and KD were assessed for differences in proportions compared with studies with broader inclusion criteria:, ∗P < .05, ∗∗P < .01, ∗∗∗P < .001.CVD, cardiovascular disorder;KD, Kawasaki disease;ns, not significant.
Figure 3
Figure 3
Proportion of patients receiving different types of treatment by study. Size ofcircles is relative to study sample size, andshapes represent categories of inclusion criteria.Gray bars represent the proportion of patients receiving treatments in all studies. Not all studies reported each type of treatment. Point labels denote studies: W = Whittaker, V = Verdoni, B = Belhadjer, T = Toubiana, D = Dufort, F = Feldstein, R = Ramcharan, and P = Pouletty. Studies with inclusion criteria of CVD and KD were assessed for differences in proportions compared with studies with broader inclusion criteria. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001.
Figure 1
Figure 1
Flowchart of literature search and study identification.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO Coronavirus Disease (COVID-19) Dashboard World Health Organization: World Health Organization. 2020.https://covid19.who.int/
    1. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702. - PubMed
    1. Garg S., Kim L., Whitaker M., O'Halloran A., Cummings C., Holstein R. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458–464. - PMC - PubMed
    1. Coronavirus Disease 2019 in Children—United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:422–426. - PMC - PubMed
    1. PICS Statement Increased number of reported cases of novel presentation of multi-system inflammatory disease. Paediatric Intensive Care Society: Paediatric Intensive Care Society. 2020.https://picsociety.uk/wp-content/uploads/2020/04/PICS-statement-re-novel... Accessed July 27, 2020.

Publication types

MeSH terms

Substances

Supplementary concepts

Related information

LinkOut - more resources

Full text links
Elsevier Science full text link Elsevier Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp